phenytoin has been researched along with vecuronium bromide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bagshaw, R; Baumgardner, JE | 1 |
| Kumar, CM; Lawler, PG | 1 |
| Gray, HS; Pollard, BJ; Slater, RM | 1 |
| Gough, JD; Smith, A; Wise, CC | 1 |
| Diaz, J; Matteo, RS; Ornstein, E; Schwartz, AE; Silverberg, PA; Young, WL | 1 |
| Bickler, PE; Cardone, C; Szenohradszky, J; Yost, S | 1 |
| Platt, PR; Thackray, NM | 1 |
| Born, JD; Brichant, JF; Hans, P; Lamy, M; Pieron, F; Pieyns, P | 1 |
| Johnson, JO; Tobias, JD | 1 |
| Greenblatt, DJ; Martyn, JA; Soriano, SG; Sullivan, LJ; Venkatakrishnan, K | 1 |
| Gronert, GA | 1 |
| Caldwell, JE; McCarthy, G; Sharma, ML; Szenohradszky, J; Wright, PM | 1 |
| Kira, S | 1 |
14 other study(ies) available for phenytoin and vecuronium bromide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Acute versus chronic phenytoin therapy and neuromuscular blockade.
Topics: Drug Interactions; Humans; Phenytoin; Vecuronium Bromide | 1990 |
Phenytoin-induced resistance to vecuronium.
Topics: Drug Resistance; Humans; Male; Middle Aged; Phenytoin; Vecuronium Bromide | 1989 |
The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade.
Topics: Adult; Humans; Infusions, Intravenous; Middle Aged; Neuromuscular Junction; Phenytoin; Time Factors; Vecuronium Bromide | 1989 |
Phenytoin-induced resistance to vecuronium.
Topics: Drug Resistance; Humans; Phenytoin; Vecuronium Bromide | 1989 |
The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
Topics: Adult; Anesthesia; Atracurium; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Female; Halothane; Humans; Male; Neuromuscular Blocking Agents; Neuromuscular Junction; Phenytoin; Vecuronium Bromide | 1987 |
Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity.
Topics: Acetylcholine; Anesthesia, General; Animals; Atracurium; Brain; Calcium; Convulsants; Dose-Response Relationship, Drug; Enflurane; Female; Glutamates; Glutamic Acid; In Vitro Techniques; Isoquinolines; Kainic Acid; Male; N-Methylaspartate; Neuromuscular Nondepolarizing Agents; Neurotoxins; Nicotine; Pancuronium; Phenytoin; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tubocurarine; Vecuronium Bromide | 1994 |
Phenytoin-induced resistance to vecuronium.
Topics: Anesthesia Recovery Period; Drug Interactions; Drug Resistance; Humans; Middle Aged; Multivariate Analysis; Neuromuscular Junction; Neurosurgery; Phenytoin; Potassium; Receptors, Cholinergic; Regression Analysis; Succinylcholine; Time Factors; Vecuronium Bromide | 1993 |
Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy.
Topics: Adult; Alprazolam; Anticonvulsants; Atropine; Biomarkers; Carbamazepine; Drug Interactions; Drug Resistance; Humans; Hydroxyzine; Hypnotics and Sedatives; Middle Aged; Neuromuscular Nondepolarizing Agents; Neurosurgery; Orosomucoid; Phenobarbital; Phenytoin; Vecuronium Bromide | 1997 |
Rapacuronium administration to patients receiving phenytoin or carbamazepine.
Topics: Adult; Anticonvulsants; Brain Injuries; Brain Neoplasms; Carbamazepine; Craniotomy; Drug Interactions; Humans; Intracranial Hypertension; Male; Monitoring, Intraoperative; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Phenytoin; Synaptic Transmission; Time Factors; Vecuronium Bromide | 2001 |
Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy.
Topics: Adolescent; Anesthesia, General; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Resistance; Electromyography; Female; Half-Life; Humans; Male; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Orosomucoid; Phenytoin; Vecuronium Bromide | 2001 |
Vecuronium sensitivity in part due to acute use of phenytoin.
Topics: Anesthesia; Anticonvulsants; Brain Death; Drug Interactions; Female; Humans; Neuromuscular Nondepolarizing Agents; Phenytoin; Vecuronium Bromide | 2002 |
Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium.
Topics: Adult; Anticonvulsants; Biotransformation; Craniotomy; Drug Interactions; Female; Humans; Male; Middle Aged; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Phenytoin; Supratentorial Neoplasms; Vecuronium Bromide | 2004 |
[Resistance to vecuronium induced muscle relaxation in a patient with mental retardation receiving phenytoin for chronic anticonvulsant therapy].
Topics: Adult; Anesthesia, General; Drug Interactions; Drug Resistance; Epilepsy; Female; Humans; Intellectual Disability; Muscle Relaxation; Neuromuscular Depolarizing Agents; Phenytoin; Time Factors; Vecuronium Bromide | 2011 |